Literature DB >> 19781432

Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.

Erika R Gehrie1, Harmony R Reynolds, Anita Y Chen, Brian H Neelon, Matthew T Roe, W Brian Gibler, E Magnus Ohman, L Kristin Newby, Eric D Peterson, Judith S Hochman.   

Abstract

BACKGROUND: Women with non-ST-segment elevation myocardial infarction (NSTEMI) who undergo coronary angiography have no obstructive coronary lesions more often than men. Sex-specific characteristics and outcomes of patients without obstructive coronary artery disease (CAD) have not been described previously.
METHODS: Using data from NSTEMI patients enrolled in CRUSADE from 2001 to 2005, we evaluated differences in clinical features and in-hospital outcomes between men and women with no obstructive CAD.
RESULTS: After excluding patients with missing catheterization and sex data (n = 1,494), previous coronary artery bypass grafting or percutaneous coronary intervention (47,907), catheterization contraindications (n = 6,588), and missing obstructive CAD status (n = 1,565), there were 55,514 patients (68.4%) with NSTE acute coronary syndromes (ACS) who underwent angiography (among women, 62.1% [21,294/34,290], and among men, 73% [34,220/46,875]; P < .001). Among these, a total of 5,538 patients (10.0%) had nonnonobstructive CAD-15.1% (3,221/21,294) of women and 6.8% (2,317/34,220) of men (P < .0001). In patients without obstructive CAD, women were as likely as men to have MI (troponin elevation in 89% vs 87%, P = .37). Women and men were equally likely to have larger troponin elevations (58.9% vs 58.6% with troponin >5x upper limit of normal, P = .69, respectively). In NSTEMI patients without obstructive CAD, in-hospital death (0.6% women vs 0.7% men) and cardiogenic shock (1.0% women vs 0.7% men) were infrequent.
CONCLUSIONS: Among NSTE ACS patients undergoing coronary angiography, absence of obstructive CAD is more common in women than men. Although nonobstructive CAD was twice as common among women with NSTEMI, sex differences in characteristics and outcomes were similar to those found with obstructive CAD. Unadjusted in-hospital outcomes of NSTEMI patients with nonobstructive CAD are favorable in both sexes. Whether the underlying pathophysiology of NSTE ACS without documentation of obstructive CAD is different between women and men requires further study.

Entities:  

Mesh:

Year:  2009        PMID: 19781432     DOI: 10.1016/j.ahj.2009.08.004

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  51 in total

Review 1.  Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.

Authors:  Carl J Pepine; Keith C Ferdinand; Leslee J Shaw; Kelly Ann Light-McGroary; Rashmee U Shah; Martha Gulati; Claire Duvernoy; Mary Norine Walsh; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2015-10-27       Impact factor: 24.094

2.  Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients.

Authors:  Gaetano M De Ferrari; Keith A A Fox; Jennifer A White; Robert P Giugliano; Pierluigi Tricoci; Harmony R Reynolds; Judith S Hochman; C Michael Gibson; Pierre Théroux; Robert A Harrington; Frans Van de Werf; Harvey D White; Robert M Califf; L Kristin Newby
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-05-09

Review 3.  Myocardial Infarction With Non-obstructive Coronary Arteries - Diagnosis and Management.

Authors:  Sivabaskari Pasupathy; Rosanna Tavella; Simon McRae; John F Beltrame
Journal:  Eur Cardiol       Date:  2015-12

4.  Coronary microvascular dysfunction in patients with acute coronary syndrome and no obstructive coronary artery disease.

Authors:  Antonio De Vita; Laura Manfredonia; Priscilla Lamendola; Angelo Villano; Salvatore Emanuele Ravenna; Antonio Bisignani; Giampaolo Niccoli; Gaetano Antonio Lanza; Filippo Crea
Journal:  Clin Res Cardiol       Date:  2019-03-29       Impact factor: 5.460

Review 5.  Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Jean C McSweeney; Anne G Rosenfeld; Willie M Abel; Lynne T Braun; Lora E Burke; Stacie L Daugherty; Gerald F Fletcher; Martha Gulati; Laxmi S Mehta; Christina Pettey; Jane F Reckelhoff
Journal:  Circulation       Date:  2016-02-29       Impact factor: 29.690

Review 6.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

8.  Stress Cardiac MRI in Women With Myocardial Infarction and Nonobstructive Coronary Artery Disease.

Authors:  Rina Mauricio; Monvadi B Srichai; Leon Axel; Judith S Hochman; Harmony R Reynolds
Journal:  Clin Cardiol       Date:  2016-07-26       Impact factor: 2.882

9.  ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.

Authors:  Deborah B Diercks; Michael C Kontos; Judd E Hollander; Bryn E Mumma; DaJuanicia N Holmes; Stephen Wiviott; Jorge F Saucedo; James A de Lemos
Journal:  Am J Emerg Med       Date:  2013-05-20       Impact factor: 2.469

Review 10.  The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women.

Authors:  LaPrincess C Brewer; Anna Svatikova; Sharon L Mulvagh
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.